Literature DB >> 16179473

An aneuploid mouse strain carrying human chromosome 21 with Down syndrome phenotypes.

Aideen O'Doherty1, Sandra Ruf, Claire Mulligan, Victoria Hildreth, Mick L Errington, Sam Cooke, Abdul Sesay, Sonie Modino, Lesley Vanes, Diana Hernandez, Jacqueline M Linehan, Paul T Sharpe, Sebastian Brandner, Timothy V P Bliss, Deborah J Henderson, Dean Nizetic, Victor L J Tybulewicz, Elizabeth M C Fisher.   

Abstract

Aneuploidies are common chromosomal defects that result in growth and developmental deficits and high levels of lethality in humans. To gain insight into the biology of aneuploidies, we manipulated mouse embryonic stem cells and generated a trans-species aneuploid mouse line that stably transmits a freely segregating, almost complete human chromosome 21 (Hsa21). This "transchromosomic" mouse line, Tc1, is a model of trisomy 21, which manifests as Down syndrome (DS) in humans, and has phenotypic alterations in behavior, synaptic plasticity, cerebellar neuronal number, heart development, and mandible size that relate to human DS. Transchromosomic mouse lines such as Tc1 may represent useful genetic tools for dissecting other human aneuploidies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16179473      PMCID: PMC1378183          DOI: 10.1126/science.1114535

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   63.714


  38 in total

Review 1.  Chromosome 21 and down syndrome: from genomics to pathophysiology.

Authors:  Stylianos E Antonarakis; Robert Lyle; Emmanouil T Dermitzakis; Alexandre Reymond; Samuel Deutsch
Journal:  Nat Rev Genet       Date:  2004-10       Impact factor: 53.242

2.  Cerebellar volume in adults with Down syndrome.

Authors:  E H Aylward; R Habbak; A C Warren; M B Pulsifer; P E Barta; M Jerram; G D Pearlson
Journal:  Arch Neurol       Date:  1997-02

3.  Germ line chimeras from female ES cells.

Authors:  A K Voss; T Thomas; P Gruss
Journal:  Exp Cell Res       Date:  1997-01-10       Impact factor: 3.905

4.  Functional expression and germline transmission of a human chromosome fragment in chimaeric mice.

Authors:  K Tomizuka; H Yoshida; H Uejima; H Kugoh; K Sato; A Ohguma; M Hayasaka; K Hanaoka; M Oshimura; I Ishida
Journal:  Nat Genet       Date:  1997-06       Impact factor: 38.330

5.  Functional screening of 2 Mb of human chromosome 21q22.2 in transgenic mice implicates minibrain in learning defects associated with Down syndrome.

Authors:  D J Smith; M E Stevens; S P Sudanagunta; R T Bronson; M Makhinson; A M Watabe; T J O'Dell; J Fung; H U Weier; J F Cheng; E M Rubin
Journal:  Nat Genet       Date:  1997-05       Impact factor: 38.330

6.  Molecular mapping of twenty-four features of Down syndrome on chromosome 21.

Authors:  J M Delabar; D Theophile; Z Rahmani; Z Chettouh; J L Blouin; M Prieur; B Noel; P M Sinet
Journal:  Eur J Hum Genet       Date:  1993       Impact factor: 4.246

7.  DSCAM: a novel member of the immunoglobulin superfamily maps in a Down syndrome region and is involved in the development of the nervous system.

Authors:  K Yamakawa; Y K Huot; M A Haendelt; R Hubert; X N Chen; G E Lyons; J R Korenberg
Journal:  Hum Mol Genet       Date:  1998-02       Impact factor: 6.150

8.  Down syndrome phenotypes: the consequences of chromosomal imbalance.

Authors:  J R Korenberg; X N Chen; R Schipper; Z Sun; R Gonsky; S Gerwehr; N Carpenter; C Daumer; P Dignan; C Disteche
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

9.  A mouse model for Down syndrome exhibits learning and behaviour deficits.

Authors:  R H Reeves; N G Irving; T H Moran; A Wohn; C Kitt; S S Sisodia; C Schmidt; R T Bronson; M T Davisson
Journal:  Nat Genet       Date:  1995-10       Impact factor: 38.330

10.  Selective neuroanatomic abnormalities in Down's syndrome and their cognitive correlates: evidence from MRI morphometry.

Authors:  N Raz; I J Torres; S D Briggs; W D Spencer; A E Thornton; W J Loken; F M Gunning; J D McQuain; N R Driesen; J D Acker
Journal:  Neurology       Date:  1995-02       Impact factor: 9.910

View more
  195 in total

Review 1.  Trisomy 21 and early brain development.

Authors:  Tarik F Haydar; Roger H Reeves
Journal:  Trends Neurosci       Date:  2011-12-09       Impact factor: 13.837

Review 2.  Cis-regulatory elements: molecular mechanisms and evolutionary processes underlying divergence.

Authors:  Patricia J Wittkopp; Gizem Kalay
Journal:  Nat Rev Genet       Date:  2011-12-06       Impact factor: 53.242

3.  Looking down the atrioventricular canal.

Authors:  D Woodrow Benson; Kristen Lipscomb Sund
Journal:  Cardiovasc Res       Date:  2010-09-20       Impact factor: 10.787

4.  Ohnologs in the human genome are dosage balanced and frequently associated with disease.

Authors:  Takashi Makino; Aoife McLysaght
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-03       Impact factor: 11.205

Review 5.  Down syndrome: from understanding the neurobiology to therapy.

Authors:  Katheleen Gardiner; Yann Herault; Ira T Lott; Stylianos E Antonarakis; Roger H Reeves; Mara Dierssen
Journal:  J Neurosci       Date:  2010-11-10       Impact factor: 6.167

6.  The chromatin-binding protein HMGN1 regulates the expression of methyl CpG-binding protein 2 (MECP2) and affects the behavior of mice.

Authors:  Liron Abuhatzira; Alon Shamir; Dustin E Schones; Alejandro A Schäffer; Michael Bustin
Journal:  J Biol Chem       Date:  2011-10-17       Impact factor: 5.157

7.  OLIG2 Drives Abnormal Neurodevelopmental Phenotypes in Human iPSC-Based Organoid and Chimeric Mouse Models of Down Syndrome.

Authors:  Ranjie Xu; Andrew T Brawner; Shenglan Li; Jing-Jing Liu; Hyosung Kim; Haipeng Xue; Zhiping P Pang; Woo-Yang Kim; Ronald P Hart; Ying Liu; Peng Jiang
Journal:  Cell Stem Cell       Date:  2019-05-23       Impact factor: 24.633

Review 8.  The cognitive phenotype of Down syndrome: insights from intracellular network analysis.

Authors:  Avi Ma'ayan; Katheleen Gardiner; Ravi Iyengar
Journal:  NeuroRx       Date:  2006-07

9.  19th International Mouse Genome Conference.

Authors:  Nicola M Solomon; Jennifer Dackor; Sally A Camper
Journal:  Mamm Genome       Date:  2006-05       Impact factor: 2.957

Review 10.  Molecular basis of pharmacotherapies for cognition in Down syndrome.

Authors:  Katheleen J Gardiner
Journal:  Trends Pharmacol Sci       Date:  2009-12-04       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.